Posted by Michael Wonder on 11 May 2020
Pricing of COVID-19 treatments and coronavirus vaccines
11 May 2020 - At least 250 drugs and 95 vaccines are currently being investigated (mostly pre-clinical) in relation to COVID-19. Gilead Sciences’ Remdesivir is the drug that’s furthest along the drug development process.
On 29 April, positive data emerged from a National Institute of Allergy and Infectious Diseases study of remdesivir. The clinical trial met an evolving primary endpoint, namely remdesivir helped COVID-19 patients recover faster.
The FDA subsequently authorised the emergency use of Remdesivir for patients hospitalised with severe cases of COVID-19.
